Fomivirsen ophthalmic Pregnancy and Breastfeeding Warnings
Brand names: Vitravene
Fomivirsen ophthalmic Pregnancy Warnings
Fomivirsen has been assigned to pregnancy category C. There are no controlled data in human pregnancy. Fomivirsen should only be given during pregnancy when benefit outweighs risks.
Fomivirsen ophthalmic Breastfeeding Warnings
There are no data on the excretion of fomivirsen into human milk. Due to the potential for serious adverse effects, a decision should be made to either discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother. In addition, HIV-infected mothers should not breast-feed their infants due to the risk of transmission of HIV via breast milk.
See also
References for pregnancy information
- Product Information. Vitravene (fomivirsen ophthalmic). Apothecon Inc. 2022.
References for breastfeeding information
- Product Information. Vitravene (fomivirsen ophthalmic). Apothecon Inc. 2022.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
